Overview

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

Status:
Active, not recruiting
Trial end date:
2023-10-31
Target enrollment:
Participant gender:
Summary
A mutilpe-center, open-label, Phase II clinical trial to evaluate the efficacy and the safety of HLX10 in combination with HLX07 in patients with advanced advanced head and neck tumors
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Henlius Biotech